AI Tumor Detection: 170+ Types Identified | RamaOnHealthcare
- A new artificial intelligence (AI) model developed by scientists in Berlin can identify more than 170 types of tumors throughout the body.
- The crossNN model analyzes epigenetic characteristics—modifications in a tumor's genetic material—to diagnose the tumor type.
- The research team is based at the Institute of Neuropathology and the Berlin Institute of Health at Charité University Hospital.
The crossNN artificial intelligence (AI) model now identifies over 170 tumor types, revolutionizing precision medicine in cancer care. This cutting-edge AI, highlighted in Nature cancer, excels at diagnosing challenging brain tumors by analyzing epigenetic characteristics. This leap in tumor identification enables personalized treatment strategies, offering hope for more effective therapies. crossNN marks a pivotal advancement in AI-driven diagnosis, promising better outcomes for patients. For insights into this and other breakthroughs, visit News Directory 3, and discover what’s next in the fight against cancer.
AI Model Identifies Tumor Types with High Accuracy
Updated June 09, 2025
A new artificial intelligence (AI) model developed by scientists in Berlin can identify more than 170 types of tumors throughout the body. The AI, dubbed crossNN, shows particular promise in diagnosing challenging brain tumors, according to a study published in Nature Cancer.
The crossNN model analyzes epigenetic characteristics—modifications in a tumor’s genetic material—to diagnose the tumor type. This AI-driven diagnosis can than inform treatment decisions, offering a precision medicine approach to tumor identification.
The research team is based at the Institute of Neuropathology and the Berlin Institute of Health at Charité University Hospital.
What’s next
The development of crossNN represents a notable step forward in the application of cognitive computing and AI to improve cancer diagnostics and treatment strategies.